Answers are grounded in this paper and cite their sources.
Doravirine (DOR) concentrations and HIV-1 RNA were evaluated in genital fluids from adults with HIV on stable therapy who switched to DOR + FTC/TAF. High protein-unbound DOR concentrations were observed in both seminal plasma and cervicovaginal fluid. DOR + FTC/TAF maintained viral suppression in genital fluids in all but 1 participant.
No takes yet. Share an insight, caveat, or question.
Scévola et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: